Baqsimi and Malnutrition - a phase IV clinical study of FDA data


Malnutrition is reported only by a few people who take Baqsimi.

The phase IV clinical study analyzes which people take Baqsimi and have Malnutrition. It is created by eHealthMe based on reports of 295 people who have side effects while taking Baqsimi from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

295 people reported to have side effects when taking Baqsimi.
Among them, 2 people (0.68%) have Malnutrition.

What is Baqsimi?

Baqsimi has active ingredients of glucagon. eHealthMe is studying from 295 Baqsimi users for its effectiveness, alternative drugs and more.

What is Malnutrition?

Malnutrition (condition that results from eating a diet in which certain nutrients are lacking) is found to be associated with 1,940 drugs and 1,270 conditions by eHealthMe.

Number of Baqsimi and Malnutrition reports submitted per year:

Could Baqsimi cause Malnutrition?

Gender of people who have Malnutrition when taking Baqsimi *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Malnutrition when taking Baqsimi *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 100 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Baqsimi *:

  1. Valproic Acid: 2 people, 100.00%
  2. Novolog: 2 people, 100.00%
  3. Ketoconazole: 2 people, 100.00%
  4. Humalog: 2 people, 100.00%
  5. Basaglar: 2 people, 100.00%

Common side effects people have besides Malnutrition *:

  1. Weight Increased: 2 people, 100.00%
  2. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 2 people, 100.00%
  3. Gait Disturbance: 2 people, 100.00%
  4. Fatigue (feeling of tiredness): 2 people, 100.00%
  5. Encephalopathy (functioning of the brain is affected by some agent or condition): 2 people, 100.00%
  6. Drug Ineffective: 2 people, 100.00%
  7. Drowsiness: 2 people, 100.00%
  8. Diarrhea: 2 people, 100.00%
  9. Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 2 people, 100.00%
  10. Diabetic Hyperglycaemic Coma (diabetic coma occurs when blood sugar gets too high and the body becomes severely dehydrated): 2 people, 100.00%

Common conditions people have *:

  1. Type 2 Diabetes: 2 people, 100.00%
  2. Type 1 Diabetes: 2 people, 100.00%
  3. Mood Swings (an extreme or rapid change in mood): 2 people, 100.00%
  4. Hypoglycemia (low blood sugar): 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Baqsimi and have Malnutrition?

Check whether Malnutrition is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Malnutrition and when was it recovered:

Expand to all the drugs that have ingredients of glucagon:

Alternative drugs to, pros and cons of Baqsimi:

Malnutrition treatments and more:

COVID vaccines that are related to Malnutrition:

Common drugs associated with Malnutrition:

All the drugs that are associated with Malnutrition:

Common conditions associated with Malnutrition:

All the conditions that are associated with Malnutrition:

How the study uses the data?

The study uses data from the FDA. It is based on glucagon (the active ingredients of Baqsimi) and Baqsimi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: